首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Atezolizumab/bevacizumabLack of efficacy
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2024年
/ 2006卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-024-57999-4
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:104 / 104
相关论文
共 50 条
[21]
BevacizumabLack of efficacy: case report
Reactions Weekly,
2024,
2032
(1)
: 89
-
89
[22]
BevacizumabLack of efficacy: case report
Reactions Weekly,
2023,
1953
(1)
: 110
-
110
[23]
BevacizumabLack of efficacy: case report
Reactions Weekly,
2023,
1983
(1)
: 106
-
106
[24]
BevacizumabLack of efficacy: case report
Reactions Weekly,
2022,
1922
(1)
: 137
-
137
[25]
BevacizumabLack of efficacy: case report
Reactions Weekly,
2022,
1896
(1)
: 89
-
89
[26]
BevacizumabLack of efficacy: case report
Reactions Weekly,
2024,
2031
(1)
: 76
-
76
[27]
BevacizumabLack of efficacy: case report
Reactions Weekly,
2021,
1871
(1)
: 95
-
95
[28]
Aflibercept/bevacizumabLack of efficacy: case report
Reactions Weekly,
2020,
1826
(1)
: 25
-
25
[29]
Aflibercept/bevacizumabLack of efficacy: case report
Reactions Weekly,
2023,
1957
(1)
: 21
-
21
[30]
BevacizumabLack of efficacy : 2 case reports
Reactions Weekly,
2023,
1953
(1)
: 109
-
109
←
1
2
3
4
5
→